Locations
Conditions
Treatments
Institutions
Resources
For researchers
About us
Clinical trials
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
Apply
\[18F\]NOTA-ABY030 with Cetuximab
Study Evaluating [18F]NOTA-ABY030 for Safety and Tolerability of Indeterminate Primary and/or Metastatic Disease in Head and Neck Squamous Cell Carcinoma
Basic information
Step 1/5
Provide your basic information
Age
ZIP code
Back
Next step